← Open Payments lookup

DIANNA CLYNE: Open Payments

NPI 1114035938 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,345 in 128 payments from 16 companies in 2025. Trend: 2023 $2,827 · 2024 $6,580 · 2025 $2,345

Food & beverage: $2,345
CompanyPaymentsAmount
ABBVIE INC.29$570
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$339
Otsuka America Pharmaceutical, Inc.20$299
Alkermes, Inc.15$267
Teva Pharmaceuticals USA, Inc.12$223
Neurocrine BioSciences, Inc.6$121
Axsome Therapeutics, Inc.6$108
Lundbeck LLC4$95
Takeda Pharmaceuticals U.S.A., Inc.3$60
E.R. Squibb & Sons, L.L.C.3$52

Products named: VRAYLAR, REXULTI, CAPLYTA, ARISTADA, UZEDY, INGREZZA, AUSTEDO XR, Auvelity.

Industry payments across NE — which companies pay providers there.